Search
IVTEAM

Pediatric CVC placement and bleeding risk

"This study compared bleeding complications in pediatric patients with a platelet count of 50 × 103/μL or above vs below 50 × 103/μL" Stokes et al (2021).

"This study compared bleeding complications in pediatric patients with a platelet count of 50 × 103/μL or above vs below 50 × 103/μL" Stokes et al (2021).

ReTweet

Pediatric CVC placement and bleeding risk

Abstract:

Tunneled central venous catheters (CVCs) are frequently required in pediatric patients with cancer, but data on platelet transfusion thresholds in this population are limited. The commonly used threshold of 50 × 103/μL (to convert platelet count to ×109/L, multiply by 1) is based on expert opinion.1,2 This study compared bleeding complications in pediatric patients with a platelet count of 50 × 103/μL or above vs below 50 × 103/μL.

Reference:

Stokes SC, Yamashiro KJ, Brown EG. Association of Thrombocytopenia With Bleeding Risk During Central Venous Catheter Placement in Pediatric Patients With Cancer. JAMA Surg. 2021 Jun 30. doi: 10.1001/jamasurg.2021.2080. Epub ahead of print. PMID: 34191023.

Facebook Twitter Linkedin Rss Envelope

About IVTEAM citation library

IVTEAM has established itself as a core global resource for infusion and vascular access practitioners. Each day 6K users have access thousands of pages of easy to access relevant intravenous news and updates. IVTEAM offers its visitors a premier service that has no financial or subscriber based restrictions. The editorial stance of IVTEAM is to ensure no editorial restrictions exist; content remains unbiased and independent.

It is crucial that IVTEAM stays up-to-date and offers visitors regular, current updates. Each day news feeds are analysed, websites searched and various additional sources of information visited. This results in large amounts of data being sifted through for relevant information every day. Only a small amount of data is relevant to IV practice and makes it onto IVTEAM.

Read more
Copyright 2024 © IVTEAM. All rights Reserved.